322 related articles for article (PubMed ID: 28026153)
21. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
[TBL] [Abstract][Full Text] [Related]
22. Prevalence, Treatment, and Outcomes of Coexistent Pulmonary Hypertension and Interstitial Lung Disease in Systemic Sclerosis.
Young A; Vummidi D; Visovatti S; Homer K; Wilhalme H; White ES; Flaherty K; McLaughlin V; Khanna D
Arthritis Rheumatol; 2019 Aug; 71(8):1339-1349. PubMed ID: 30762947
[TBL] [Abstract][Full Text] [Related]
23. Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide.
Rose L; Prins KW; Archer SL; Pritzker M; Weir EK; Misialek JR; Thenappan T
J Heart Lung Transplant; 2019 Feb; 38(2):145-155. PubMed ID: 30391191
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary vascular resistance estimated by Doppler echocardiography predicts mortality in patients with interstitial lung disease.
Yasui K; Yuda S; Abe K; Muranaka A; Otsuka M; Ohnishi H; Hashimoto A; Takahashi H; Tsuchihashi K; Takahashi H; Takahashi S; Miura T
J Cardiol; 2016 Oct; 68(4):300-7. PubMed ID: 27032318
[TBL] [Abstract][Full Text] [Related]
25. Impact of pulmonary hypertension on exercise performance in patients with interstitial lung disease undergoing evaluation for lung transplantation.
Armstrong HF; Schulze PC; Bacchetta M; Thirapatarapong W; Bartels MN
Respirology; 2014 Jul; 19(5):675-82. PubMed ID: 24797365
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics of pulmonary hypertension in bronchiectasis.
Wang L; Jiang S; Shi J; Gong S; Zhao Q; Jiang R; Yuan P; Pudasaini B; He J; Jing Z; Liu J
Front Med; 2016 Sep; 10(3):336-44. PubMed ID: 27527360
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients.
Cottin V; Harari S; Humbert M; Mal H; Dorfmüller P; Jaïs X; Reynaud-Gaubert M; Prevot G; Lazor R; Taillé C; Lacronique J; Zeghmar S; Simonneau G; Cordier JF;
Eur Respir J; 2012 Sep; 40(3):630-40. PubMed ID: 22362861
[TBL] [Abstract][Full Text] [Related]
28. Right Ventricular to Left Ventricular Ratio at CT Pulmonary Angiogram Predicts Mortality in Interstitial Lung Disease.
Bax S; Jacob J; Ahmed R; Bredy C; Dimopoulos K; Kempny A; Kokosi M; Kier G; Renzoni E; Molyneaux PL; Chua F; Kouranos V; George P; McCabe C; Wilde M; Devaraj A; Wells A; Wort SJ; Price LC
Chest; 2020 Jan; 157(1):89-98. PubMed ID: 31351047
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary arterial wall disease in COPD and interstitial lung diseases candidates for lung transplantation.
Domingo E; Grignola JC; Aguilar R; Messeguer ML; Roman A
Respir Res; 2017 May; 18(1):85. PubMed ID: 28477618
[TBL] [Abstract][Full Text] [Related]
30. How can autoantibodies predict the long-term outcome of patients with interstitial lung disease? Results from a retrospective cohort study.
Kampolis CF; Venetsanopoulou AI; Karakontaki F; Polychronopoulos V; Vlachoyiannopoulos P; Tzioufas AG
Autoimmun Rev; 2018 Nov; 17(11):1124-1133. PubMed ID: 30213691
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension: clinical characteristics and impact of pulmonary arterial hypertension therapies.
Le Pavec J; Lorillon G; Jaïs X; Tcherakian C; Feuillet S; Dorfmüller P; Simonneau G; Humbert M; Tazi A
Chest; 2012 Nov; 142(5):1150-1157. PubMed ID: 22459770
[TBL] [Abstract][Full Text] [Related]
32. [Clinical interpretation for the pressure-flow relationships in extrinsic allergic alveolitis and in interstitial lung disease pulmonary hypertension patients. Should we care for the lung, the pulmonary artery pressure or both?].
Lupi-Herrera E; Santos-Martínez LE; Pulido T; Sandoval J
Arch Cardiol Mex; 2009; 79(2):91-103. PubMed ID: 19722378
[TBL] [Abstract][Full Text] [Related]
33. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.
Weitzenblum E; Chaouat A; Canuet M; Kessler R
Semin Respir Crit Care Med; 2009 Aug; 30(4):458-70. PubMed ID: 19634085
[TBL] [Abstract][Full Text] [Related]
35. The strengths and weaknesses of non-invasive parameters obtained by echocardiography and cardiopulmonary exercise testing in comparison with the hemodynamic assessment by the right heart catheterization in patients with pulmonary hypertension.
Ptaszyńska-Kopczyńska K; Krentowska A; Sawicka E; Skoneczny A; Jasiewicz M; Knapp M; Musiał WJ; Sobkowicz B; Kamiński KA
Adv Med Sci; 2017 Mar; 62(1):39-44. PubMed ID: 28187374
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
[TBL] [Abstract][Full Text] [Related]
37. Acute hemodynamic responses to supplemental oxygen and their prognostic implications in pulmonary hypertension.
Leuchte HH; Baezner CJ; Baumgartner RA; Mernitz P; Neurohr C; Behr J
Respiration; 2013; 85(5):400-7. PubMed ID: 23037927
[TBL] [Abstract][Full Text] [Related]
38. Hemodynamic heterogeneity of connective tissue disease patients with borderline mean pulmonary artery pressure and its distinctive characters from those with normal pulmonary artery pressure: a retrospective study.
Asari Y; Yamasaki Y; Tsuchida K; Suzuki K; Akashi YJ; Okazaki T; Ozaki S; Yamada H; Kawahata K
Clin Rheumatol; 2018 Dec; 37(12):3373-3380. PubMed ID: 29777409
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary Hemodynamics and Six-Minute Walk Test Outcomes in Patients with Interstitial Lung Disease.
Nishiyama O; Yamazaki R; Sano H; Iwanaga T; Higashimoto Y; Kume H; Tohda Y
Can Respir J; 2016; 2016():3837182. PubMed ID: 27445533
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterization.
Keir GJ; Wort SJ; Kokosi M; George PM; Walsh SLF; Jacob J; Price L; Bax S; Renzoni EA; Maher TM; MacDonald P; Hansell DM; Wells AU
Respirology; 2018 Jul; 23(7):687-694. PubMed ID: 29327393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
